We have a balanced practice advising strategic investors, financial investors as well as emerging companies at any stage of the "venture capital lifecycle" - whether early, mid-stage or late stage and growth equity or last dollars before an exit, and beyond.
This means that we have a unique ability to understand perspectives from all sides of the table which is critical in developing solutions that help investors and innovators stay ahead of the curve.
Our lawyers are highly experienced in their local markets and are firmly embedded within their local ecosystems, but also connected with each other in sharing ideas and opportunities, leveraging our unique worldwide reach and capability to provide international insight to our clients.
Fast growth businesses are transforming every industry with disruptive business models. Our industry focus enables us to identify, and anticipate regulatory changes, market dynamics, and trends that will redefine the shape of an industry. We have our finger on the pulse. We can help spot investment opportunities and support growth companies to learn and change.
Our world leading regulatory expertise means we don't just understand regulation; we can shape it, challenge it and navigate it. Just as we can help investors to understand, identify and deal with regulatory risks affecting their investments, we can help growth businesses leverage regulation to become stronger where it matters.
Accel, Eurazeo and various investors on Sorare's record $680m Series B, valuing it at $4.3bn.
Verkor, a French industrial company, on its record financing of more than €2bn to launch a high-performance battery gigafactory in France.
Walmart on its joint venture with Ribbit Capital to create a new fintech start-up.
Gilead Sciences on its investment in the US$120m Series B financing of AlloVir, formerly known as ViraCyte.
FlixMobility on its Series F funding round. This transaction is one of the largest equity financing rounds ever completed in Germany.
Norwest Venture Partners on a number of investments including on its Series D-2 investment in Grove Collaborative and on its investment in Algorithmia’s US$25m Series B financing round.
Iberis Capital, a Portugal-based private equity and venture capital firm, on its Series C investment in Kevel, a U.S.-based API-led ad-serving company.
The Exploration Company, a Franco-German spacecraft manufacturer, on its US$160m Series B financing round to fund continued development of its Nyx spacecraft, Europe’s first reusable space capsule.
OncoVerity, a pioneer in applying advanced bioinformatics to drug development, on the closing of a Series A extension financing led by existing investors, argenx and RefinedScience.
Apis Global Growth Fund III, a fund managed by Apis Partners, a private equity and venture capital asset manager supporting growth-stage financial services and technology businesses, as lead investor on a c. £70m investment in Moneybox, a digital wealth management platform.
Area of Focus
Area of Focus
Area of Focus
Area of Focus
Area of Focus
Area of Focus
Area of Focus
Area of Focus
